Document is current
Any future updates will be listed below
-
Authors
El Miedany, Yasser https://orcid.org/0000-0002-4543-692X
Abu-Zaid, Mohammed Hassan https://orcid.org/0000-0001-8436-8598
El Gaafary, Maha https://orcid.org/0000-0002-3948-3826
Mansour, Mona
Fathy, Nihal
Hassan, Waleed https://orcid.org/0000-0002-3238-6804
Mortada, Mohamed https://orcid.org/0000-0002-7198-9878
Eissa, Mervat https://orcid.org/0000-0001-7999-3401
Tabra, Samar Abdelhamed https://orcid.org/0000-0001-6414-5602
Galal, Salwa https://orcid.org/0000-0002-5010-2959
Foad, Nermeen https://orcid.org/0000-0002-6461-4939
Ibrahim, Rehab Ali https://orcid.org/0000-0003-3741-9940
Medhat, Basma https://orcid.org/0000-0001-6944-6367
El Olemy, Gehan https://orcid.org/0000-0001-5196-8300
Adel, Yasmin https://orcid.org/0000-0002-2798-2353
Ghaleb, Rasha https://orcid.org/0000-0003-4283-9034
Saber, Sally https://orcid.org/0000-0001-8162-4699
GadAllah, Naglaa
- License Information
-
More Information
Article History
Received: 18 July 2022
Accepted: 6 September 2022
First Online: 10 October 2022
Declarations
:
: This study was performed in accordance with the Helsinki Declaration. This was a multistep process which followed the ‘Clinical, Evidence-based, Guidelines’ (CEG) initiative protocol (ethical approval code: 34842/8/21, ethical board Tanta University) aiming at setting up an actionable clinical gold standard for treat-to-target management of rheumatic and bone diseases.
: Not applicable
: The authors declare that Mona Mansour is editor in chief. Mohammed Hassan Abu-Zaid, Salwa Galal, and Rehab Ali are associate editors in the Egyptian Rheumatology and Rehabilitation. Mohammed Mortada, Yasser El Miedany, Naglaa Gadallah, and Waleed Hassan are from editorial board of the journal. The other authors declare that they have no competing interests.
